| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 17, 2026 | Sell(S) | 263 | $4.55 | $1K | 12K |
| Aug 15, 2026 | Option exercise(M) | 722 | — | — | 13K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 15, 2026 | Option exercise(M) | 390 | — | $0 | 783 |
| Aug 15, 2026 | Option exercise(M) | 332 | — | $0 | 2K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-355722) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Seres Therapeutics, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001193125-26-355722"
Use Arkolith to summarize insider buying and selling at Seres Therapeutics, Inc. over the last 90 days and cite the filings.